Effects of SGLT2 Inhibitors by Background Cardiovascular Medications
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis
Diabetes Obes Metab 2023 Jul 12;[EPub Ahead of Print], I Avgerinos, T Karagiannis, DR Matthews, A Tsapas, E BekiariFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.